DEF DAILY TARG 2X L LMND ETF (LMNX) Stock Price, Forecast & Analysis

NASDAQ:LMNX • US88636W7671

20.9464 USD
+0.94 (+4.69%)
Last: Feb 13, 2026, 08:21 PM

LMNX Key Statistics, Chart & Performance

Key Statistics
Market Cap991.06M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares47.31M
Float26.61M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-01
IPO2000-03-30
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
LMNX short term performance overview.The bars show the price performance of LMNX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

LMNX long term performance overview.The bars show the price performance of LMNX in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of LMNX is 20.9464 USD. In the past month the price decreased by -42.9%.

DEF DAILY TARG 2X L LMND ETF / LMNX Daily stock chart

LMNX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
LMNX Full Technical Analysis Report

LMNX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC20.34189.666B
DHR DANAHER CORP25.03150.273B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28133.2444.271B
A AGILENT TECHNOLOGIES INC20.7835.584B
IQV IQVIA HOLDINGS INC12.7628.313B
MTD METTLER-TOLEDO INTERNATIONAL29.4427.668B
WAT WATERS CORP22.3519.25B
WST WEST PHARMACEUTICAL SERVICES31.9118.02B
ILMN ILLUMINA INC22.5617.849B
MEDP MEDPACE HOLDINGS INC25.4612.058B

DEF DAILY TARG 2X L LMND ETF / LMNX FAQ

What does LMNX do?

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company is headquartered in Austin, Texas and currently employs 1,325 full-time employees. The company went IPO on 2000-03-30. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The firm primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.


What is the stock price of DEF DAILY TARG 2X L LMND ETF today?

The current stock price of LMNX is 20.9464 USD. The price increased by 4.69% in the last trading session.


What is the ChartMill technical and fundamental rating of LMNX stock?

LMNX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Is DEF DAILY TARG 2X L LMND ETF (LMNX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LMNX.